Consano Bio, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Mar 20, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Dec 12, 2025 · D | Mar 20, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $16,840,000 | $48,858,795 | $32,018,795 |
| Reported amount sold | $16,840,000 | $34,824,466 | $17,984,466 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001981285-25-000005 · Later SEC source: 0001981285-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $48,858,795
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $34,824,466
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001981285-26-000001D · Mar 20, 2026 · BiotechnologyOffering: $48,858,795Sold: $34,824,466
Compared with 0001981285-25-000005:
- Reported offering amount: $16,840,000 → $48,858,795
- Reported amount sold: $16,840,000 → $34,824,466
-
0001981285-25-000005D · Dec 12, 2025 · BiotechnologyOffering: $16,840,000Sold: $16,840,000